Vipsen

Vipsen Pharma is a comprehensive pharmaceutical enterprise based in China, focusing on the R&D, production, and sales of active pharmaceutical ingredients (APIs) and finished drug products. The company has established a significant presence in the antiviral market, notably as a major manufacturer of Oseltamivir Phosphate for the treatment and prevention of influenza. Vipsen operates state-of-the-art manufacturing bases in the China Medical City (CMC) of Jiangsu province that adhere to global GMP standards. Their product pipeline and commercial portfolio cover diverse therapeutic sectors, including infectious diseases, cardiovascular health, and metabolic disorders. The company integrates advanced chemical synthesis with large-scale production capabilities to provide cost-effective medical solutions to both domestic and international markets.